ICU Medical (ICUI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $2.44 | $2.07 | 17.9 % |
| Q2 | Aug 6, 2026 | $2.37 | $1.82 | 30.2 % |
| Q1 | May 7, 2026 | $1.97 | $1.67 | 18.0 % |
| Q4 | Feb 19, 2026 | $1.91 | $1.54 | 24.0 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $560.44M | $553.79M | 1.20 % |
| Q2 | Aug 6, 2026 | $551.70M | $534.02M | 3.31 % |
| Q1 | May 7, 2026 | $530.20M | $528.88M | 0.25 % |
| Q4 | Feb 19, 2026 | $540.70M | $536.31M | 0.82 % |
ICU Medical (ICUI) emitió su última guía sobre noviembre 5, 2026 para fiscal year 2026. La compañía estimó unas ganancias por acción en el rango de $8.6 - $9, en comparación con una estimación de consenso de EPS de $8.45.
En comparación con la previsión anterior, ICU Medical mantenido redujo su previsión de BPA desde un rango anterior de $8.6 - $9.
ICU Medical ha emitido 14 actualizaciones de orientación entre el febrero 27, 2023 y el noviembre 5, 2026. During this period, the company raised its outlook 7 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.07 | $1.82 | $1.67 | $1.54 |
| Actual | $2.44 | $2.37 | $1.97 | $1.91 |
| Surprise | +17.9% | +30.2% | +18.0% | +24.0% |
| Revenue | ||||
| Estimate | $553.8M | $534.0M | $528.9M | $536.3M |
| Actual | $560.4M | $551.7M | $530.2M | $540.7M |
| Surprise | +1.20% | +3.31% | +0.25% | +0.82% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.08 | $2.05 | $1.97 | $2.12 |
| Revenue | ||||
| Consensus | $560.3M | $545.6M | — | — |
